seed
Stage
1
Investors
About
Immunicom develops immunotherapies using its Immunopheresis® technology, a therapeutic device that filters blood outside the body to remove immune-blocking factors, aiming to treat cancer and other diseases by enhancing the immune response.
Explore Immunicom's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.